No Handouts for Drug Advertisements Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 5
- Latest action
- Apr 24, 2025
What it does
The bill would amend the Internal Revenue Code to disallow tax deductions for advertising and promotional expenses related to direct-to-consumer advertising of certain prescription and compounded drugs. It affects pharmaceutical companies and entities that sponsor prescription drugs or operate outsourcing facilities, prohibiting them from deducting costs for ads targeting the general public via TV, radio, internet, social media, billboards, and similar channels. Ads published in medical journals or other professional periodicals would be exempt from this restriction. The change would apply to expenses incurred after the bill’s enactment.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.